Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The influence of disulfiram on the half life and metabolic clearance rate of diphenylhydantoin and tolbtamide in man.

Literature DB >> 971708

The influence of disulfiram on the half life and metabolic clearance rate of diphenylhydantoin and tolbtamide in man.

T L Svendsen, M B Kristensen, J M Hansen, L Skovsted.

Abstract

Diphenylhydantoin (DPH) and tolbutamide serum levels were studied in ten volunteers before and after 4 days of disulfiram treatment. The mean DPH half life increased significantly from 11.0 +/- a.2 h to 19.0 +/- 3.3 h, and the mean DPH metabolic clearance rate decreased significantly from 51.2 +/- 17.2 ml/min to 33.9 +/- 12.0 ml/min during medication. No significant changes in the half life or metabolic clearance rate of tolbutamide was observed.

Entities: Chemical Species

Mesh：

Substances：

Year: 1976 PMID： 971708 DOI： 10.1007/BF00606562

Source DB: PubMed Journal: Eur J Clin Pharmacol ISSN： 0031-6970 Impact factor: 2.953

13 in total

1. [The possibility of colorimetric determination of N-(4-methyl-benzolsulfonyl)-N'-butyl urea in blood].

Authors: H SPINGLER
Journal: Klin Wochenschr Date: 1957-05-15

2. [Special pharmacological research with D-860].

Authors: A BANDER; J SCHOLZ
Journal: Dtsch Med Wochenschr Date: 1956-06-01 Impact factor: 0.628

3. Sulfamethizole-induced inhibition of diphenlhydantoin, tolbutamide, and warfarin metabolism.

Authors: B Lumholtz; K Siersbaek-Nielsen; L Skovsted; J Kampmann; J M Hansen
Journal: Clin Pharmacol Ther Date: 1975-06 Impact factor: 6.875

4. Potentiation of the tolbutamide effect by dicoumarol.

Authors: M Kristensen; J M Hansen
Journal: Diabetes Date: 1967-04 Impact factor: 9.461

5. Dicoumarol-induced diphenylhydantoin intoxication.

Authors: J M Hansen; M Kristensen; L Skovsted; L K Christensen
Journal: Lancet Date: 1966-07-30 Impact factor: 79.321

6. Sulthiame (Ospolot) as inhibitor of diphenylhydatoin metabolism.

Authors: J M Hansen; M Kristensen; L Skovsted
Journal: Epilepsia Date: 1968-03 Impact factor: 5.864

7. Inhibition of drug metabolism by chloramphenicol.

Authors: L K Christensen; L Skovsted
Journal: Lancet Date: 1969-12-27 Impact factor: 79.321

8. Impairment of drug metabolism by disulfiram in man.

Authors: E S Vesell; G T Passananti; C H Lee
Journal: Clin Pharmacol Ther Date: 1971 Sep-Oct Impact factor: 6.875

9. The influence of disulfiram and calcium carbimide on the serum diphenylhydantoin. Excretion of HPPH in the urine.

Authors: O V Olesen
Journal: Arch Neurol Date: 1967-06

10. Disulfiramum (antabuse) as inhibitor of phenytoin metabolism.

Authors: O V Olesen
Journal: Acta Pharmacol Toxicol (Copenh) Date: 1966

12 in total

Review 1. Treatment of concomitant illnesses in patients receiving anticonvulsants: drug interactions of clinical significance.

Authors: P Loiseau
Journal: Drug Saf Date: 1998-12 Impact factor: 5.606

Review 2. Pharmacokinetic drug interactions with phenytoin (Part II).

Authors: R L Nation; A M Evans; R W Milne
Journal: Clin Pharmacokinet Date: 1990-02 Impact factor: 6.447

Review 3. Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors: D I Quinn; A Wodak; R O Day
Journal: Clin Pharmacokinet Date: 1997-11 Impact factor: 6.447

Review 4. Clinical features and management of poisoning due to phenytoin.

Authors: J R Larsen; L S Larsen
Journal: Med Toxicol Adverse Drug Exp Date: 1989 Jul-Aug

Review 5. Importance of multi-p450 inhibition in drug-drug interactions: evaluation of incidence, inhibition magnitude, and prediction from in vitro data.

Authors: Nina Isoherranen; Justin D Lutz; Sophie P Chung; Houda Hachad; Rene H Levy; Isabelle Ragueneau-Majlessi
Journal: Chem Res Toxicol Date: 2012-09-27 Impact factor: 3.739

6. Microsomal prediction of in vivo clearance of CYP2C9 substrates in humans.

Authors: D J Carlile; N Hakooz; M K Bayliss; J B Houston
Journal: Br J Clin Pharmacol Date: 1999-06 Impact factor: 4.335

7. Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects.

Authors: Reginald F Frye; Robert A Branch
Journal: Br J Clin Pharmacol Date: 2002-02 Impact factor: 4.335